Sign up to save your podcasts
Or
Share Dr. Gideon Blumenthal (Pt 2): Working to Balance Access, Efficacy, and Safety at the FDA
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Dr. Gideon Blumenthal (Pt 2): Working to Balance Access, Efficacy, and Safety at the FDA
Dr. West questions Dr. Gideon Blumenthal of the FDA about how he and his team there struggle to provide timely access to emerging cancer treatments, while also debating questions of the proper thresholds for efficacy and safety.
View all episodes
By H. Jack West, MD
5
22 ratings
Dr. West questions Dr. Gideon Blumenthal of the FDA about how he and his team there struggle to provide timely access to emerging cancer treatments, while also debating questions of the proper thresholds for efficacy and safety.